Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
AstraZeneca
Kivu Bioscience Inc.
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Aveni Foundation
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Arvinas Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
A2 Biotherapeutics Inc.
Eli Lilly and Company
St. Jude Children's Research Hospital
Poseida Therapeutics, Inc.
MacroGenics
Unity Health Toronto
xCures
Daiichi Sankyo
SN BioScience
University of Nebraska
Cue Biopharma
Eli Lilly and Company
EXoPERT
Adela, Inc
National Institutes of Health Clinical Center (CC)
Imperial College London
Second Life Therapeutics
Eli Lilly and Company
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)